Cross-Site Scripting Vulnerability in Intel EMA Software
CVE-2022-30297

7.8HIGH

Key Information:

Vendor

Intel
Status
Intel(r) Ema Software
Vendor
CVE Published:
11 November 2022

What is CVE-2022-30297?

A cross-site scripting vulnerability exists in Intel EMA software prior to version 1.8.0 that could allow a privileged user to enable potential privilege escalation through local access. This vulnerability can expose the system to further attacks if exploited, jeopardizing user data and system integrity.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Intel(R) EMA software before version 1.8.0

References

https://www.intel.com/content/www/us/en/security-center/a...

CVSS V3.1

Score:
7.8
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.